LifeStance Health Group Inc. Common Stock (LFST)
Stock · NASDAQ · Health Care
$11.73as of 10/16/2026
Price chart
Active signals
LFST Signal Track Record
How signals performed across all stocks →What LFST's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | +4.8% | 62% | September 9, 2026 |
| Bollinger Band Breakout | 28 | +2.8% | 57% | September 14, 2026 |
| Bollinger Band Breakdown | 24 | +4.0% | 63% | September 24, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -15.9% | 27% | April 9, 2025 |
| Any 20-session window (baseline) | +0.9% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental…
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Employees
- 8,542
- Website
- investor.lifestance.com/
Fundamentals
- 1-day range
- $12.32$12.62
- Market cap
- $4.13B
- P/E (trailing)
- 93.42
- P/E (forward)
- 28.72
- EPS (trailing)
- $0.13
- Dividend yield
- —
- Beta
- 1.32
- Avg. volume
- 4.28M
How LifeStance Health Group Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub
Forecasts
10 analyst ratings
LifeStance Health Group Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LFSTLifeStance Health Group Inc. Common Stock$11.74▼ 5.09%Market cap $4.13BP/E 93.42$4.77$13.56
- OPCHOption Care Health Inc. Common Stock$31.2▼ 0.06%Market cap $3.54BP/E 22.23$18.01$36.8
- PRVAPrivia Health Group Inc. Common Stock$22.52▼ 0.44%Market cap $2.77BP/E 102.74$18.92$28.82
- ADUSAddus HomeCare Corporation Common Stock$115.98▼ 0.44%Market cap $2.22BP/E 20.70$87.95$124.44
- WGSGeneDx Holdings Corp. Class A Common Stock$63.61▼ 9.41%Market cap $2.08BP/E —$32.21$170.87
- AVAHAveanna Healthcare Holdings Inc. Common Stock$12.34▼ 2.37%Market cap $2.03BP/E 10.04$5.93$14.71
- INNVInnovAge Holding Corp. Common Stock$8.85▼ 1.45%Market cap $1.49BP/E —$3.94$12.64
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LFST LifeStance Health Group Inc. Common Stock | $4.13B | 93.42 | $11.74 | ▼ 5.09% | $4.77$13.56 |
| OPCH Option Care Health Inc. Common Stock | $3.54B | 22.23 | $31.2 | ▼ 0.06% | $18.01$36.8 |
| PRVA Privia Health Group Inc. Common Stock | $2.77B | 102.74 | $22.52 | ▼ 0.44% | $18.92$28.82 |
| ADUS Addus HomeCare Corporation Common Stock | $2.22B | 20.70 | $115.98 | ▼ 0.44% | $87.95$124.44 |
| WGS GeneDx Holdings Corp. Class A Common Stock | $2.08B | — | $63.61 | ▼ 9.41% | $32.21$170.87 |
| AVAH Aveanna Healthcare Holdings Inc. Common Stock | $2.03B | 10.04 | $12.34 | ▼ 2.37% | $5.93$14.71 |
| INNV InnovAge Holding Corp. Common Stock | $1.49B | — | $8.85 | ▼ 1.45% | $3.94$12.64 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Transcript: LifeStance Health Gr Q2 2026 Earnings Conference CallBenzinga · 10/7/2026
- 3 Stocks Under $50 We Keep Off Our RadarYahoo · 10/5/2026
- Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15Benzinga · 10/5/2026
- 3 Healthcare Stocks That Concern UsYahoo · 10/2/2026
- Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey FindsYahoo · 9/30/2026
- What’s Going On With LifeStance Health Group (LFST)?Yahoo · 9/28/2026
- LifeStance Health CTO Sells 42,067 Shares for $541,402Yahoo · 9/23/2026
- LifeStance Health Group (LFST): Buy, Sell, or Hold Post Q2 Earnings?Yahoo · 9/21/2026
Insider Activity
Insider Actions →- David Bourdon · September 22, 2026 · Gift150.0K
- TPG GP A, LLC · September 11, 2026 · Sale18.41M @ $12.29
- Vukasin Paunovich · September 2, 2026 · Sale42.1K @ $12.87
- David Bourdon · September 2, 2026 · J150.0K
- Ann Varanakis · August 24, 2026 · Tax Withholding8.2K @ $12.16
- Teresa DeLuca · August 14, 2026 · Sale7.5K @ $12.68
- Teresa DeLuca · August 13, 2026 · Sale20.4K @ $12.23
- Kenneth A. Burdick · August 11, 2026 · Sale500.0K @ $11.51
- Vukasin Paunovich · August 10, 2026 · Sale44.4K @ $10.85
- Lisa K. Miller · August 10, 2026 · Sale47.9K @ $10.85
- TPG GP A, LLC · August 10, 2026 · Sale13.64M @ $10.62
- Kenneth A. Burdick · July 6, 2026 · Grant45.5K
- Robert Bessler · July 2, 2026 · Grant17.7K
- Thurman Justice · July 2, 2026 · Grant35.5K
- Lori Goltermann · July 2, 2026 · Grant35.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 356.56M
- Total value held
- $2.27B
- Institutional holders
- 218
- Unknown140.03M
- Unknown58.69M
- Unknown29.21M
- Unknown18.13M
- Unknown10.37M
- Unknown10.23M
- Unknown7.91M
- Unknown6.16M
- Unknown6.09M
- Unknown4.73M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.